The catalyst are actually already in place for this to start the ascent . However due to an across the board lack of understanding and many people waiting until volume picks up the stock still flounders in obscurity . Like I have mentioned several times comparing it to other medical technology advances it really is not that surprising .
Once prototypes are available and investors and medical professionals actually are able to evaluate the system and the capabilities the entire landscape will change in my opinion of course .
The startling thing I have noticed is how little interest it takes to kick it up a dollar or so. Many many people watching and waiting will end up in probably around the 2.60 range or 2.45 if they can catch it on the climb . Patience is so often rewarded those that are actual investors and not looking to make the odd dime or quarter should be vastly rewarded based on my past experience .
My treatment regime for this company is 20ccs of time and 60ccs of patience . If that doesn't work take 2 Advil and call me in 12 - 18 months .
The theories on Google and Johnson and Johnson are interesting but my hopes are we go it alone . That scenario promotes the highest value but least likely as the space will only heat up and the interest from outside companies will dramatically increase . Obviously we do not have a lot of buyers at this particular time but we also don't have a lot of sellers .
News 
Market Data 
Discover 
AI
